Scholarlink

<p>Photodynamic therapy (PDT) is a clinically established modality that induces localized cell death through the light activation of a photosensitizer (PS). While celebrated for its exceptional cosmetic outcomes, PDT protocols remain largely empirical, and their efficacy is influenced by complex factors beyond simple photochemical yield. A critical paradigm shift has highlighted that the subcellular localization of the PS is a more decisive factor for cell death efficiency than the total load of reactive species generated. Consequently, targeting PSs to vital organelles like mitochondria, lysosomes, and the endoplasmic reticulum has become a primary focus for improving therapeutic selectivity. This review provides a comprehensive overview of advanced polymeric nanocarriers engineered for this precise subcellular targeting. We examine the role of these nanoplatforms as both protective drug carriers and active targeting agents, emphasizing their advantages in stability, biocompatibility, and modular design. The discussion critically assesses the therapeutic potential and inherent challenges of targeting specific organelles to optimize the efficacy-to-toxicity ratio. The integration of polymer science with photobiology and nanomedicine is presented as a promising frontier for the rational development of superior PDT treatments.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Polymeric nanocarriers for subcellular targeting in photodynamic therapy

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月12日

查看全文
  • Ieda Vieira da Cunha,
  • Isabela Lopes e Cytrângolo,
  • Maurício S. Baptista,
  • Tayana Mazin Tsubone

摘要

Photodynamic therapy (PDT) is a clinically established modality that induces localized cell death through the light activation of a photosensitizer (PS). While celebrated for its exceptional cosmetic outcomes, PDT protocols remain largely empirical, and their efficacy is influenced by complex factors beyond simple photochemical yield. A critical paradigm shift has highlighted that the subcellular localization of the PS is a more decisive factor for cell death efficiency than the total load of reactive species generated. Consequently, targeting PSs to vital organelles like mitochondria, lysosomes, and the endoplasmic reticulum has become a primary focus for improving therapeutic selectivity. This review provides a comprehensive overview of advanced polymeric nanocarriers engineered for this precise subcellular targeting. We examine the role of these nanoplatforms as both protective drug carriers and active targeting agents, emphasizing their advantages in stability, biocompatibility, and modular design. The discussion critically assesses the therapeutic potential and inherent challenges of targeting specific organelles to optimize the efficacy-to-toxicity ratio. The integration of polymer science with photobiology and nanomedicine is presented as a promising frontier for the rational development of superior PDT treatments.

Graphical abstract